nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—ALOX5—hematologic cancer	0.207	0.608	CbGaD
Aminosalicylic Acid—L-DOPA—Melphalan—hematologic cancer	0.149	1	CrCrCtD
Aminosalicylic Acid—MPO—hematologic cancer	0.133	0.392	CbGaD
Aminosalicylic Acid—PTGS2—Lenalidomide—hematologic cancer	0.0476	0.183	CbGbCtD
Aminosalicylic Acid—MPO—Cisplatin—hematologic cancer	0.0315	0.121	CbGbCtD
Aminosalicylic Acid—PTGS2—Thalidomide—hematologic cancer	0.0254	0.0979	CbGbCtD
Aminosalicylic Acid—PTGS1—Bortezomib—hematologic cancer	0.0246	0.0949	CbGbCtD
Aminosalicylic Acid—PTGS1—Thalidomide—hematologic cancer	0.0214	0.0826	CbGbCtD
Aminosalicylic Acid—PTGS1—Ifosfamide—hematologic cancer	0.0189	0.0728	CbGbCtD
Aminosalicylic Acid—PTGS1—Imatinib—hematologic cancer	0.018	0.0695	CbGbCtD
Aminosalicylic Acid—PTGS2—Triamcinolone—hematologic cancer	0.0176	0.0678	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—hematologic cancer	0.0151	0.0582	CbGbCtD
Aminosalicylic Acid—PTGS2—Cisplatin—hematologic cancer	0.0109	0.0419	CbGbCtD
Aminosalicylic Acid—PTGS2—Etoposide—hematologic cancer	0.0107	0.0412	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—hematologic cancer	0.00902	0.0348	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—hematologic cancer	0.00879	0.0339	CbGbCtD
Aminosalicylic Acid—PTGS2—ovarian follicle—hematologic cancer	0.00441	0.172	CbGeAlD
Aminosalicylic Acid—CHUK—hematopoietic system—hematologic cancer	0.00246	0.0962	CbGeAlD
Aminosalicylic Acid—CHUK—blood—hematologic cancer	0.00163	0.0638	CbGeAlD
Aminosalicylic Acid—L-DOPA—PSIP1—hematologic cancer	0.00143	0.621	CrCbGaD
Aminosalicylic Acid—CHUK—lung—hematologic cancer	0.00143	0.0559	CbGeAlD
Aminosalicylic Acid—ALOX5—hematopoietic system—hematologic cancer	0.00139	0.0542	CbGeAlD
Aminosalicylic Acid—CHUK—testis—hematologic cancer	0.00135	0.0527	CbGeAlD
Aminosalicylic Acid—MPO—hematopoietic system—hematologic cancer	0.00117	0.0459	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—hematologic cancer	0.000979	0.0382	CbGeAlD
Aminosalicylic Acid—ALOX5—blood—hematologic cancer	0.00092	0.0359	CbGeAlD
Aminosalicylic Acid—ALOX5—bone marrow—hematologic cancer	0.00089	0.0348	CbGeAlD
Aminosalicylic Acid—ALOX5—lung—hematologic cancer	0.000806	0.0315	CbGeAlD
Aminosalicylic Acid—MPO—blood—hematologic cancer	0.000778	0.0304	CbGeAlD
Aminosalicylic Acid—ALOX5—testis—hematologic cancer	0.000761	0.0297	CbGeAlD
Aminosalicylic Acid—MPO—bone marrow—hematologic cancer	0.000753	0.0294	CbGeAlD
Aminosalicylic Acid—MPO—lung—hematologic cancer	0.000682	0.0266	CbGeAlD
Aminosalicylic Acid—MPO—testis—hematologic cancer	0.000644	0.0251	CbGeAlD
Aminosalicylic Acid—PTGS1—hematopoietic system—hematologic cancer	0.000557	0.0218	CbGeAlD
Aminosalicylic Acid—ALOX5—lymph node—hematologic cancer	0.000551	0.0215	CbGeAlD
Aminosalicylic Acid—PTGS2—hematopoietic system—hematologic cancer	0.000533	0.0208	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—hematologic cancer	0.000466	0.0182	CbGeAlD
Aminosalicylic Acid—Mesalazine—ALOX5—hematologic cancer	0.000395	0.171	CrCbGaD
Aminosalicylic Acid—PTGS1—blood—hematologic cancer	0.000369	0.0144	CbGeAlD
Aminosalicylic Acid—PTGS2—blood—hematologic cancer	0.000353	0.0138	CbGeAlD
Aminosalicylic Acid—PTGS2—bone marrow—hematologic cancer	0.000341	0.0133	CbGeAlD
Aminosalicylic Acid—PTGS1—lung—hematologic cancer	0.000324	0.0126	CbGeAlD
Aminosalicylic Acid—PTGS2—lung—hematologic cancer	0.000309	0.0121	CbGeAlD
Aminosalicylic Acid—PTGS1—testis—hematologic cancer	0.000305	0.0119	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000274	0.209	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000274	0.209	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000268	0.205	CbGdCrCtD
Aminosalicylic Acid—Mesalazine—MPO—hematologic cancer	0.000254	0.11	CrCbGaD
Aminosalicylic Acid—PTGS1—lymph node—hematologic cancer	0.000221	0.00864	CbGeAlD
Aminosalicylic Acid—PTGS2—lymph node—hematologic cancer	0.000212	0.00826	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000165	0.126	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000165	0.126	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000162	0.124	CbGdCrCtD
Aminosalicylic Acid—Diflunisal—ALB—hematologic cancer	0.000108	0.0469	CrCbGaD
Aminosalicylic Acid—Salicylic acid—ALB—hematologic cancer	6.02e-05	0.0261	CrCbGaD
Aminosalicylic Acid—Salicylic acid—ABCB1—hematologic cancer	5.75e-05	0.0249	CrCbGaD
Aminosalicylic Acid—Dermatitis—Bleomycin—hematologic cancer	4.1e-05	0.000338	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ifosfamide—hematologic cancer	4.1e-05	0.000338	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinorelbine—hematologic cancer	4.08e-05	0.000336	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gemcitabine—hematologic cancer	4.07e-05	0.000336	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Thalidomide—hematologic cancer	4.05e-05	0.000334	CcSEcCtD
Aminosalicylic Acid—Dizziness—Thiotepa—hematologic cancer	4.05e-05	0.000334	CcSEcCtD
Aminosalicylic Acid—Rash—Vinorelbine—hematologic cancer	4.04e-05	0.000333	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vinorelbine—hematologic cancer	4.04e-05	0.000333	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—hematologic cancer	4.04e-05	0.000333	CcSEcCtD
Aminosalicylic Acid—Headache—Vinorelbine—hematologic cancer	4.02e-05	0.000331	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—hematologic cancer	4e-05	0.00033	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—hematologic cancer	3.92e-05	0.000323	CcSEcCtD
Aminosalicylic Acid—Dizziness—Thalidomide—hematologic cancer	3.92e-05	0.000323	CcSEcCtD
Aminosalicylic Acid—Nausea—Bortezomib—hematologic cancer	3.9e-05	0.000322	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mitoxantrone—hematologic cancer	3.9e-05	0.000321	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Irinotecan—hematologic cancer	3.9e-05	0.000321	CcSEcCtD
Aminosalicylic Acid—Vomiting—Thiotepa—hematologic cancer	3.89e-05	0.000321	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carmustine—hematologic cancer	3.89e-05	0.000321	CcSEcCtD
Aminosalicylic Acid—Nausea—Bleomycin—hematologic cancer	3.87e-05	0.000319	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—hematologic cancer	3.86e-05	0.000319	CcSEcCtD
Aminosalicylic Acid—Rash—Thiotepa—hematologic cancer	3.86e-05	0.000318	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Thiotepa—hematologic cancer	3.86e-05	0.000318	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Alitretinoin—hematologic cancer	3.85e-05	0.000318	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—hematologic cancer	3.85e-05	0.000318	CcSEcCtD
Aminosalicylic Acid—Headache—Thiotepa—hematologic cancer	3.84e-05	0.000316	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Etoposide—hematologic cancer	3.82e-05	0.000315	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ifosfamide—hematologic cancer	3.81e-05	0.000314	CcSEcCtD
Aminosalicylic Acid—Nausea—Vinorelbine—hematologic cancer	3.81e-05	0.000314	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	3.8e-05	0.000313	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cisplatin—hematologic cancer	3.79e-05	0.000313	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—hematologic cancer	3.79e-05	0.000312	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—hematologic cancer	3.77e-05	0.000311	CcSEcCtD
Aminosalicylic Acid—Vomiting—Thalidomide—hematologic cancer	3.76e-05	0.000311	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carmustine—hematologic cancer	3.76e-05	0.00031	CcSEcCtD
Aminosalicylic Acid—Rash—Thalidomide—hematologic cancer	3.73e-05	0.000308	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Thalidomide—hematologic cancer	3.73e-05	0.000308	CcSEcCtD
Aminosalicylic Acid—Dizziness—Alitretinoin—hematologic cancer	3.73e-05	0.000307	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vincristine—hematologic cancer	3.71e-05	0.000306	CcSEcCtD
Aminosalicylic Acid—Headache—Thalidomide—hematologic cancer	3.71e-05	0.000306	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—hematologic cancer	3.71e-05	0.000306	CcSEcCtD
Aminosalicylic Acid—Dizziness—Ifosfamide—hematologic cancer	3.68e-05	0.000304	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—hematologic cancer	3.66e-05	0.000302	CcSEcCtD
Aminosalicylic Acid—Nausea—Thiotepa—hematologic cancer	3.64e-05	0.0003	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—hematologic cancer	3.63e-05	0.0003	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—hematologic cancer	3.63e-05	0.000299	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mitoxantrone—hematologic cancer	3.62e-05	0.000298	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Irinotecan—hematologic cancer	3.62e-05	0.000298	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carmustine—hematologic cancer	3.62e-05	0.000298	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—hematologic cancer	3.61e-05	0.000297	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—hematologic cancer	3.6e-05	0.000297	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—hematologic cancer	3.59e-05	0.000296	CcSEcCtD
Aminosalicylic Acid—Rash—Carmustine—hematologic cancer	3.59e-05	0.000296	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carmustine—hematologic cancer	3.58e-05	0.000295	CcSEcCtD
Aminosalicylic Acid—Vomiting—Alitretinoin—hematologic cancer	3.58e-05	0.000295	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—hematologic cancer	3.57e-05	0.000294	CcSEcCtD
Aminosalicylic Acid—Headache—Carmustine—hematologic cancer	3.56e-05	0.000294	CcSEcCtD
Aminosalicylic Acid—Rash—Alitretinoin—hematologic cancer	3.55e-05	0.000293	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—hematologic cancer	3.55e-05	0.000293	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—hematologic cancer	3.55e-05	0.000293	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Alitretinoin—hematologic cancer	3.55e-05	0.000293	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—hematologic cancer	3.54e-05	0.000292	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—hematologic cancer	3.54e-05	0.000292	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ifosfamide—hematologic cancer	3.54e-05	0.000292	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cisplatin—hematologic cancer	3.54e-05	0.000292	CcSEcCtD
Aminosalicylic Acid—Headache—Alitretinoin—hematologic cancer	3.53e-05	0.000291	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gemcitabine—hematologic cancer	3.52e-05	0.000291	CcSEcCtD
Aminosalicylic Acid—Nausea—Thalidomide—hematologic cancer	3.52e-05	0.00029	CcSEcCtD
Aminosalicylic Acid—Rash—Ifosfamide—hematologic cancer	3.51e-05	0.00029	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ifosfamide—hematologic cancer	3.51e-05	0.000289	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.51e-05	0.000289	CcSEcCtD
Aminosalicylic Acid—Dizziness—Irinotecan—hematologic cancer	3.5e-05	0.000288	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—hematologic cancer	3.49e-05	0.000288	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—hematologic cancer	3.49e-05	0.000288	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Etoposide—hematologic cancer	3.48e-05	0.000287	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—hematologic cancer	3.48e-05	0.000287	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—hematologic cancer	3.47e-05	0.000286	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—hematologic cancer	3.45e-05	0.000285	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—hematologic cancer	3.45e-05	0.000285	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—hematologic cancer	3.45e-05	0.000285	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—hematologic cancer	3.45e-05	0.000284	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—hematologic cancer	3.43e-05	0.000283	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—hematologic cancer	3.42e-05	0.000282	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—hematologic cancer	3.42e-05	0.000282	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—hematologic cancer	3.4e-05	0.000281	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—hematologic cancer	3.4e-05	0.000281	CcSEcCtD
Aminosalicylic Acid—Nausea—Carmustine—hematologic cancer	3.38e-05	0.000279	CcSEcCtD
Aminosalicylic Acid—Vomiting—Irinotecan—hematologic cancer	3.36e-05	0.000277	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mitoxantrone—hematologic cancer	3.36e-05	0.000277	CcSEcCtD
Aminosalicylic Acid—Nausea—Alitretinoin—hematologic cancer	3.35e-05	0.000276	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—hematologic cancer	3.34e-05	0.000275	CcSEcCtD
Aminosalicylic Acid—Rash—Irinotecan—hematologic cancer	3.33e-05	0.000275	CcSEcCtD
Aminosalicylic Acid—Rash—Mitoxantrone—hematologic cancer	3.33e-05	0.000275	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mitoxantrone—hematologic cancer	3.33e-05	0.000275	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Irinotecan—hematologic cancer	3.33e-05	0.000275	CcSEcCtD
Aminosalicylic Acid—Headache—Mitoxantrone—hematologic cancer	3.31e-05	0.000273	CcSEcCtD
Aminosalicylic Acid—Headache—Irinotecan—hematologic cancer	3.31e-05	0.000273	CcSEcCtD
Aminosalicylic Acid—Nausea—Ifosfamide—hematologic cancer	3.31e-05	0.000273	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cisplatin—hematologic cancer	3.28e-05	0.000271	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gemcitabine—hematologic cancer	3.27e-05	0.00027	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.27e-05	0.000269	CcSEcCtD
Aminosalicylic Acid—Rash—Gemcitabine—hematologic cancer	3.25e-05	0.000268	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gemcitabine—hematologic cancer	3.24e-05	0.000268	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etoposide—hematologic cancer	3.24e-05	0.000267	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—hematologic cancer	3.23e-05	0.000266	CcSEcCtD
Aminosalicylic Acid—Headache—Gemcitabine—hematologic cancer	3.23e-05	0.000266	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—hematologic cancer	3.22e-05	0.000266	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—hematologic cancer	3.21e-05	0.000265	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—hematologic cancer	3.2e-05	0.000264	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—hematologic cancer	3.17e-05	0.000261	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—hematologic cancer	3.17e-05	0.000261	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—hematologic cancer	3.16e-05	0.000261	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—hematologic cancer	3.15e-05	0.00026	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—hematologic cancer	3.15e-05	0.00026	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—hematologic cancer	3.15e-05	0.000259	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—hematologic cancer	3.15e-05	0.000259	CcSEcCtD
Aminosalicylic Acid—Nausea—Irinotecan—hematologic cancer	3.14e-05	0.000259	CcSEcCtD
Aminosalicylic Acid—Nausea—Mitoxantrone—hematologic cancer	3.14e-05	0.000259	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.12e-05	0.000258	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.12e-05	0.000258	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—hematologic cancer	3.09e-05	0.000255	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—hematologic cancer	3.06e-05	0.000253	CcSEcCtD
Aminosalicylic Acid—Nausea—Gemcitabine—hematologic cancer	3.06e-05	0.000252	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cisplatin—hematologic cancer	3.05e-05	0.000252	CcSEcCtD
Aminosalicylic Acid—Rash—Cisplatin—hematologic cancer	3.03e-05	0.00025	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cisplatin—hematologic cancer	3.02e-05	0.000249	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—hematologic cancer	3.02e-05	0.000249	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—hematologic cancer	3.01e-05	0.000248	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—hematologic cancer	3e-05	0.000248	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—hematologic cancer	2.98e-05	0.000246	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—hematologic cancer	2.98e-05	0.000245	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.96e-05	0.000244	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	2.96e-05	0.000244	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—hematologic cancer	2.96e-05	0.000244	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—hematologic cancer	2.94e-05	0.000242	CcSEcCtD
Aminosalicylic Acid—Dizziness—Etoposide—hematologic cancer	2.91e-05	0.00024	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—hematologic cancer	2.89e-05	0.000238	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—hematologic cancer	2.88e-05	0.000237	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—hematologic cancer	2.88e-05	0.000237	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—hematologic cancer	2.87e-05	0.000237	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—hematologic cancer	2.86e-05	0.000236	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—hematologic cancer	2.86e-05	0.000236	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—hematologic cancer	2.86e-05	0.000236	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—hematologic cancer	2.86e-05	0.000236	CcSEcCtD
Aminosalicylic Acid—Nausea—Cisplatin—hematologic cancer	2.85e-05	0.000235	CcSEcCtD
Aminosalicylic Acid—Vomiting—Etoposide—hematologic cancer	2.8e-05	0.000231	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—hematologic cancer	2.79e-05	0.000231	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—hematologic cancer	2.79e-05	0.00023	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—hematologic cancer	2.77e-05	0.000229	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—hematologic cancer	2.77e-05	0.000228	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—hematologic cancer	2.76e-05	0.000227	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—hematologic cancer	2.75e-05	0.000227	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Prednisone—hematologic cancer	2.74e-05	0.000226	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—hematologic cancer	2.74e-05	0.000226	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—hematologic cancer	2.73e-05	0.000226	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—hematologic cancer	2.73e-05	0.000225	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.73e-05	0.000225	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—hematologic cancer	2.72e-05	0.000224	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—hematologic cancer	2.7e-05	0.000223	CcSEcCtD
Aminosalicylic Acid—Dizziness—Triamcinolone—hematologic cancer	2.64e-05	0.000218	CcSEcCtD
Aminosalicylic Acid—Nausea—Etoposide—hematologic cancer	2.61e-05	0.000215	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—hematologic cancer	2.58e-05	0.000213	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—hematologic cancer	2.58e-05	0.000213	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—hematologic cancer	2.58e-05	0.000213	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—hematologic cancer	2.58e-05	0.000213	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—hematologic cancer	2.58e-05	0.000212	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—hematologic cancer	2.56e-05	0.000211	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.55e-05	0.000211	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—hematologic cancer	2.54e-05	0.000209	CcSEcCtD
Aminosalicylic Acid—Rash—Triamcinolone—hematologic cancer	2.52e-05	0.000207	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—hematologic cancer	2.51e-05	0.000207	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—hematologic cancer	2.51e-05	0.000207	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—hematologic cancer	2.5e-05	0.000207	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—hematologic cancer	2.5e-05	0.000206	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—hematologic cancer	2.5e-05	0.000206	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—hematologic cancer	2.49e-05	0.000206	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—hematologic cancer	2.49e-05	0.000206	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—hematologic cancer	2.48e-05	0.000204	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—hematologic cancer	2.48e-05	0.000204	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—hematologic cancer	2.42e-05	0.000199	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—hematologic cancer	2.41e-05	0.000199	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—hematologic cancer	2.39e-05	0.000197	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—hematologic cancer	2.39e-05	0.000197	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dexamethasone—hematologic cancer	2.39e-05	0.000197	CcSEcCtD
Aminosalicylic Acid—Nausea—Triamcinolone—hematologic cancer	2.37e-05	0.000195	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.36e-05	0.000195	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—hematologic cancer	2.35e-05	0.000194	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—hematologic cancer	2.32e-05	0.000192	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—hematologic cancer	2.29e-05	0.000189	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.27e-05	0.000188	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—hematologic cancer	2.27e-05	0.000187	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—hematologic cancer	2.27e-05	0.000187	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—hematologic cancer	2.24e-05	0.000184	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—hematologic cancer	2.23e-05	0.000184	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—hematologic cancer	2.22e-05	0.000183	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—hematologic cancer	2.17e-05	0.000179	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Prednisone—hematologic cancer	2.16e-05	0.000178	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	2.15e-05	0.000178	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—hematologic cancer	2.15e-05	0.000177	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—hematologic cancer	2.15e-05	0.000177	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.13e-05	0.000176	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—hematologic cancer	2.09e-05	0.000173	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—hematologic cancer	2.08e-05	0.000172	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—hematologic cancer	2.08e-05	0.000172	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—hematologic cancer	2.08e-05	0.000172	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	2.02e-05	0.000166	CcSEcCtD
Aminosalicylic Acid—Vomiting—Prednisone—hematologic cancer	2e-05	0.000165	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisone—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—hematologic cancer	1.98e-05	0.000164	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—hematologic cancer	1.97e-05	0.000163	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.97e-05	0.000162	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—hematologic cancer	1.96e-05	0.000162	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—hematologic cancer	1.95e-05	0.000161	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—hematologic cancer	1.95e-05	0.000161	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—hematologic cancer	1.94e-05	0.00016	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—hematologic cancer	1.87e-05	0.000154	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.87e-05	0.000154	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—hematologic cancer	1.82e-05	0.00015	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—hematologic cancer	1.81e-05	0.000149	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—hematologic cancer	1.8e-05	0.000149	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—hematologic cancer	1.8e-05	0.000149	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—hematologic cancer	1.8e-05	0.000149	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—hematologic cancer	1.74e-05	0.000144	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—hematologic cancer	1.69e-05	0.000139	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—hematologic cancer	1.68e-05	0.000139	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—hematologic cancer	1.67e-05	0.000138	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—hematologic cancer	1.65e-05	0.000136	CcSEcCtD
Aminosalicylic Acid—Dizziness—Epirubicin—hematologic cancer	1.63e-05	0.000134	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—hematologic cancer	1.57e-05	0.000129	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—hematologic cancer	1.56e-05	0.000129	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—hematologic cancer	1.56e-05	0.000129	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—hematologic cancer	1.55e-05	0.000128	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—hematologic cancer	1.55e-05	0.000128	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—hematologic cancer	1.54e-05	0.000127	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—hematologic cancer	1.51e-05	0.000124	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—hematologic cancer	1.45e-05	0.00012	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—hematologic cancer	1.44e-05	0.000119	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—hematologic cancer	1.44e-05	0.000119	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—hematologic cancer	1.43e-05	0.000118	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—hematologic cancer	1.35e-05	0.000112	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRB2—hematologic cancer	3.62e-06	3.58e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFA—hematologic cancer	3.61e-06	3.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD44—hematologic cancer	3.61e-06	3.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYCS—hematologic cancer	3.6e-06	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.58e-06	3.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FOS—hematologic cancer	3.58e-06	3.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BAD—hematologic cancer	3.58e-06	3.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HSP90AA1—hematologic cancer	3.58e-06	3.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CREB1—hematologic cancer	3.57e-06	3.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KITLG—hematologic cancer	3.56e-06	3.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CBL—hematologic cancer	3.55e-06	3.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SDC1—hematologic cancer	3.55e-06	3.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—hematologic cancer	3.54e-06	3.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.53e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—hematologic cancer	3.5e-06	3.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6R—hematologic cancer	3.49e-06	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CREBBP—hematologic cancer	3.48e-06	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT5A—hematologic cancer	3.48e-06	3.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—hematologic cancer	3.47e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—hematologic cancer	3.47e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—hematologic cancer	3.45e-06	3.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTPN11—hematologic cancer	3.4e-06	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.39e-06	3.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HSP90AA1—hematologic cancer	3.39e-06	3.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.35e-06	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD86—hematologic cancer	3.33e-06	3.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAP2K1—hematologic cancer	3.32e-06	3.28e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—hematologic cancer	3.31e-06	3.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CD—hematologic cancer	3.3e-06	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CREB1—hematologic cancer	3.3e-06	3.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—hematologic cancer	3.29e-06	3.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—hematologic cancer	3.28e-06	3.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT1—hematologic cancer	3.27e-06	3.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCOR1—hematologic cancer	3.27e-06	3.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—hematologic cancer	3.26e-06	3.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF1—hematologic cancer	3.23e-06	3.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSF2—hematologic cancer	3.23e-06	3.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.22e-06	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6R—hematologic cancer	3.22e-06	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CREBBP—hematologic cancer	3.21e-06	3.18e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.2e-06	3.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FOXO1—hematologic cancer	3.18e-06	3.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRB—hematologic cancer	3.18e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—hematologic cancer	3.17e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGF2—hematologic cancer	3.16e-06	3.12e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—EP300—hematologic cancer	3.15e-06	3.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—hematologic cancer	3.15e-06	3.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFRA—hematologic cancer	3.13e-06	3.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAK1—hematologic cancer	3.12e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCG—hematologic cancer	3.12e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3R1—hematologic cancer	3.12e-06	3.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.07e-06	3.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAP2K1—hematologic cancer	3.07e-06	3.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GRB2—hematologic cancer	3.06e-06	3.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFA—hematologic cancer	3.05e-06	3.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CD—hematologic cancer	3.05e-06	3.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JAK2—hematologic cancer	3.03e-06	2.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NQO1—hematologic cancer	3.02e-06	2.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD44—hematologic cancer	3.02e-06	2.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—hematologic cancer	3.01e-06	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KITLG—hematologic cancer	3.01e-06	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—hematologic cancer	3e-06	2.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—hematologic cancer	3e-06	2.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—hematologic cancer	2.97e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.96e-06	2.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MDM2—hematologic cancer	2.96e-06	2.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT5A—hematologic cancer	2.94e-06	2.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGF2—hematologic cancer	2.92e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—hematologic cancer	2.92e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NCOR1—hematologic cancer	2.92e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—hematologic cancer	2.91e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2RA—hematologic cancer	2.91e-06	2.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—hematologic cancer	2.89e-06	2.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—hematologic cancer	2.88e-06	2.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3R1—hematologic cancer	2.88e-06	2.85e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—hematologic cancer	2.88e-06	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CB—hematologic cancer	2.88e-06	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—hematologic cancer	2.87e-06	2.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYCS—hematologic cancer	2.86e-06	2.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HSP90AA1—hematologic cancer	2.84e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD86—hematologic cancer	2.82e-06	2.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDGFB—hematologic cancer	2.81e-06	2.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JAK2—hematologic cancer	2.8e-06	2.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—hematologic cancer	2.78e-06	2.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—hematologic cancer	2.78e-06	2.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCOR1—hematologic cancer	2.76e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC2—hematologic cancer	2.75e-06	2.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF1—hematologic cancer	2.73e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MDM2—hematologic cancer	2.73e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—hematologic cancer	2.7e-06	2.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FOXO1—hematologic cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRB—hematologic cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—hematologic cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—hematologic cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—hematologic cancer	2.66e-06	2.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CB—hematologic cancer	2.66e-06	2.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—hematologic cancer	2.65e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—hematologic cancer	2.65e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFRA—hematologic cancer	2.65e-06	2.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR3—hematologic cancer	2.64e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—hematologic cancer	2.64e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCG—hematologic cancer	2.64e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAK1—hematologic cancer	2.64e-06	2.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK14—hematologic cancer	2.62e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—hematologic cancer	2.58e-06	2.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—hematologic cancer	2.57e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—hematologic cancer	2.57e-06	2.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.56e-06	2.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—hematologic cancer	2.54e-06	2.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—hematologic cancer	2.52e-06	2.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKBIA—hematologic cancer	2.51e-06	2.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BAD—hematologic cancer	2.51e-06	2.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—hematologic cancer	2.49e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—hematologic cancer	2.49e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—hematologic cancer	2.49e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—hematologic cancer	2.48e-06	2.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—hematologic cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—hematologic cancer	2.44e-06	2.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.44e-06	2.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—hematologic cancer	2.44e-06	2.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—hematologic cancer	2.44e-06	2.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—hematologic cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—hematologic cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—hematologic cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—hematologic cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—hematologic cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTPN11—hematologic cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PDGFB—hematologic cancer	2.38e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EP300—hematologic cancer	2.37e-06	2.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—hematologic cancer	2.36e-06	2.34e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—hematologic cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TSC2—hematologic cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NCOR1—hematologic cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—hematologic cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CREB1—hematologic cancer	2.31e-06	2.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—hematologic cancer	2.3e-06	2.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—hematologic cancer	2.3e-06	2.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—hematologic cancer	2.29e-06	2.27e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—hematologic cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—hematologic cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6R—hematologic cancer	2.25e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CREBBP—hematologic cancer	2.25e-06	2.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR3—hematologic cancer	2.24e-06	2.21e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—hematologic cancer	2.22e-06	2.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—hematologic cancer	2.22e-06	2.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EP300—hematologic cancer	2.19e-06	2.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—hematologic cancer	2.17e-06	2.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAP2K1—hematologic cancer	2.15e-06	2.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CD—hematologic cancer	2.13e-06	2.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—hematologic cancer	2.13e-06	2.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—hematologic cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BAD—hematologic cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—hematologic cancer	2.1e-06	2.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—hematologic cancer	2.06e-06	2.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—hematologic cancer	2.05e-06	2.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—hematologic cancer	2.05e-06	2.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—hematologic cancer	2.05e-06	2.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—hematologic cancer	2.05e-06	2.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGF2—hematologic cancer	2.04e-06	2.02e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTPN11—hematologic cancer	2.02e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3R1—hematologic cancer	2.01e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CREBBP—hematologic cancer	2.01e-06	1.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—hematologic cancer	1.96e-06	1.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAK2—hematologic cancer	1.96e-06	1.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CREB1—hematologic cancer	1.95e-06	1.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—hematologic cancer	1.93e-06	1.91e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MDM2—hematologic cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—hematologic cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—hematologic cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6R—hematologic cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—hematologic cancer	1.91e-06	1.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.9e-06	1.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CREBBP—hematologic cancer	1.9e-06	1.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—hematologic cancer	1.9e-06	1.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—hematologic cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CB—hematologic cancer	1.86e-06	1.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—hematologic cancer	1.86e-06	1.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAP2K1—hematologic cancer	1.82e-06	1.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CD—hematologic cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3R1—hematologic cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—hematologic cancer	1.76e-06	1.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—hematologic cancer	1.75e-06	1.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—hematologic cancer	1.75e-06	1.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGF2—hematologic cancer	1.73e-06	1.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—hematologic cancer	1.72e-06	1.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—hematologic cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—hematologic cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3R1—hematologic cancer	1.7e-06	1.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—hematologic cancer	1.66e-06	1.65e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—hematologic cancer	1.66e-06	1.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CB—hematologic cancer	1.66e-06	1.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAK2—hematologic cancer	1.66e-06	1.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MDM2—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CREBBP—hematologic cancer	1.59e-06	1.58e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CB—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—hematologic cancer	1.55e-06	1.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EP300—hematologic cancer	1.53e-06	1.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CD—hematologic cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—hematologic cancer	1.5e-06	1.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—hematologic cancer	1.49e-06	1.47e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—hematologic cancer	1.48e-06	1.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—hematologic cancer	1.45e-06	1.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—hematologic cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—hematologic cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—hematologic cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—hematologic cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—hematologic cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3R1—hematologic cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—hematologic cancer	1.37e-06	1.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—EP300—hematologic cancer	1.37e-06	1.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—hematologic cancer	1.36e-06	1.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—hematologic cancer	1.36e-06	1.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—hematologic cancer	1.34e-06	1.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—hematologic cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—hematologic cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CB—hematologic cancer	1.32e-06	1.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EP300—hematologic cancer	1.3e-06	1.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—hematologic cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—hematologic cancer	1.23e-06	1.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—hematologic cancer	1.22e-06	1.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—hematologic cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—hematologic cancer	1.16e-06	1.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—hematologic cancer	1.14e-06	1.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—hematologic cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—hematologic cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—hematologic cancer	1.13e-06	1.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—hematologic cancer	1.1e-06	1.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EP300—hematologic cancer	1.09e-06	1.07e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—hematologic cancer	1.05e-06	1.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—hematologic cancer	1.04e-06	1.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.01e-06	1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—hematologic cancer	1e-06	9.93e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—hematologic cancer	9.59e-07	9.48e-06	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—hematologic cancer	9.26e-07	9.16e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—hematologic cancer	8.87e-07	8.77e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—hematologic cancer	8.49e-07	8.4e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—hematologic cancer	8.26e-07	8.17e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—hematologic cancer	8.03e-07	7.94e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—hematologic cancer	7.83e-07	7.75e-06	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—hematologic cancer	6.56e-07	6.49e-06	CbGpPWpGaD
